SLC25A17 may play a role in the tumorigenesis, development and efficacy of cancer; however, the application value of SLC25A17 as a biomarker in head and neck squamous cell carcinoma has not been explored. This evidence concerns the gene SLC25A17 and head and neck squamous cell carcinoma.